Comment on "A randomized double-blind trial of intranasal dexmedetomidine versus intranasal esketamine for procedural sedation and analgesia in young children".
Scandinavian journal of trauma, resuscitation and emergency medicine – May 13, 2025
Source: PubMed
Summary
When sedating young children for medical procedures, choosing the right medication is crucial. This analysis examines a comparison between dexmedetomidine and esketamine nasal sprays. While initial results seemed promising, the small sample size of 29 children limited statistical confidence. The review highlights concerns about safety and delayed medication effects, suggesting careful consideration before clinical use.
Abstract
This comment critiques a trial comparing intranasal dexmedetomidine (DEX) and esketamine (sKET) for pediatric procedural sedation. Despite a large effect size, the small sample (n = 29) likely caused false-negative results (p = 0.09), necessitating larger trials. Safety concerns (e.g., aspiration risk), unaddressed long-term psychological outcomes, and limited pharmacokinetic data (delayed DEX onset, prolonged duration) challenge clinical applicability. Future studies should integrate objective measures and long-term follow-up.